Eligible for Vaccination Against Influenza Completed Phase 1 / 2 Trials for Influenza A virus A/Brisbane/59/2007 (H1N1) hemagglutinin antigen (formaldehyde inactivated) (DB14618)

IndicationStatusPhase
DBCOND0049621 (Eligible for Vaccination Against Influenza)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01248208FluMist in Egg Allergic PatientsPrevention